Behavioral Measures of Vision
Behavioral Measures of Vision
批准号:
8542849
负责人:
RONALD S HARWERTH
金额:
$35.74万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1978
资助国家:
美国
项目状态:
已结题
起止时间:
1978-01-01 至 2017-08-31
关键词:
AffectAgeAge-YearsAreaAxonBehavioralBiometryBlindnessBrainCaringCharacteristicsClinicClinicalClinical ManagementClinical ResearchComplexDataDefectDiagnosisDimensionsDiseaseDisease ManagementDisease ProgressionEarly DiagnosisEvaluationEventExperimental ModelsEyeFunctional disorderGlaucomaGoalsGrantHumanImageIndividualInstitutesInvestigationKnowledgeLaboratoriesLaboratory StudyLinkMacacaMapsMeasurementMeasuresMethodsModelingMonkeysNerve FibersNeuronal DysfunctionNeuronsNeuropathyOptic DiskOptic NerveOptical Coherence TomographyPathologyPatientsPatternPerimetryPhasePopulationPrimatesProceduresPsychophysiologyPublic HealthResearchResearch MethodologyResolutionRetinaRetinalRetinal Ganglion CellsScanningScotomaSeveritiesStagingStructureStructure-Activity RelationshipTechniquesTestingThickTimeTranslatingTranslationsUnited StatesUniversitiesVisionVisualVisual FieldsVisually Impaired PersonsWorkage effectbasebehavior measurementclinical Diagnosisclinical applicationclinically relevantcostdesigneffective therapyhuman dataimprovedlegally blindmaculaneuron lossneuronal cell bodyoptic nerve disorderpatient populationpreventrelating to nervous systemresearch studyretinal nerve fiber layerretinal neuronspecies differencetreatment effect
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Glaucoma is a progressive optic neuropathy caused by a pathological loss of the retinal neurons that form the optic nerve from the eye to the brain. t is a leading cause of irreversible blindness in the United States; approximately 2.2 million people older than 40 years of age suffer from the disease and as many as 120,000 of these people are blind from glaucoma. As the population ages, the disease will become an increasingly important problem of public health, but treatments are effective in preventing or slowing vision loss and it is, therefore, important to optimize procedures for determining if treatment is needed and if it is effective. Because the cause of glaucoma is unknown, the diagnosis or progression of disease requires ophthalmic testing to identify and quantify clinical characteristics of glaucomatous neuropathy, such as the pattern of visual field defects, anatomical changes of the optic nerve head, and losses of retinal ganglion cells and axons. The goal of the proposed research is to gain a better understanding of the relationships between clinical measures of neural and visual losses from glaucoma, especially the psycho-physiological links between structure and function. The principal experiments involve behavioral studies of visual function (standard automated perimetry) and high resolution imaging of retinal structure (optical coherence tomography) over the time course of experimental glaucoma in macaque monkeys. The data from the investigations of experimental glaucoma will be used to 1) develop a quantitative model relating the loss of retinal neurons in a specific area of the retia to the number of axons entering the optic nerve from the same retinal area and 2) To investigate the temporal relationships of the clinical signs of glaucomatous neuropathy that involve losses in visual sensitivity, increased cupping of the optic nerve head, and thinning of the neuronal layers of the inner retina. In the final phase, the relationships that were derived from experimental glaucoma in monkeys will be applied to assess the severity, or stage, of glaucoma in human patients. The research method is based on defining procedures with experimental glaucoma where there are excellent controls for the experimental and measurement variables and, then, application to human patients to test the clinical relevance and validity of the procedures. This method of going from the laboratory to the clinic should maximize the potential for significant new information about ophthalmic testing for translation to the diagnosis and assessment of glaucoma. Key words: glaucoma, retinal ganglion cells, retinal nerve fiber layer, perimetry, OCT, optic nerve head, monkeys, humans
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CORE--COMPUTER PROGRAMMING
-
批准号:6721599
-
项目类别:
-
资助金额:$12.62万
-
财政年份:2003
-
负责人:RONALD S HARWERTH
-
依托单位:
CORE--COMPUTER PROGRAMMING
-
批准号:6572314
-
项目类别:
-
资助金额:$8.64万
-
财政年份:2002
-
负责人:RONALD S HARWERTH
-
依托单位:
CORE--COMPUTER PROGRAMMING
-
批准号:6442571
-
项目类别:
-
资助金额:$8.64万
-
财政年份:2001
-
负责人:RONALD S HARWERTH
-
依托单位:
CORE--COMPUTER PROGRAMMING
-
批准号:6301618
-
项目类别:
-
资助金额:$12.56万
-
财政年份:2000
-
负责人:RONALD S HARWERTH
-
依托单位:
CORE--COMPUTER PROGRAMMING
-
批准号:6106959
-
项目类别:
-
资助金额:$12.56万
-
财政年份:1999
-
负责人:RONALD S HARWERTH
-
依托单位:
CORE--COMPUTER PROGRAMMING
-
批准号:6271435
-
项目类别:
-
资助金额:$11.59万
-
财政年份:1998
-
负责人:RONALD S HARWERTH
-
依托单位:
CORE--COMPUTER PROGRAMMING
-
批准号:6239850
-
项目类别:
-
资助金额:$8.51万
-
财政年份:1997
-
负责人:RONALD S HARWERTH
-
依托单位:
SMALL INSTRUMENTATION GRANT
-
批准号:2165062
-
项目类别:
-
资助金额:$1.26万
-
财政年份:1994
-
负责人:RONALD S HARWERTH
-
依托单位:
SMALL INSTRUMENTATION GRANT
-
批准号:3524494
-
项目类别:
-
资助金额:$1.0万
-
财政年份:1990
-
负责人:RONALD S HARWERTH
-
依托单位:
BEHAVIORAL MEASURES OF BINOCULAR VISION
-
批准号:2634370
-
项目类别:
-
资助金额:$23.57万
-
财政年份:1978
-
负责人:RONALD S HARWERTH
-
依托单位:
BEHAVIORAL MEASURES OF BINOCULAR VISION
-
批准号:3255707
-
项目类别:
-
资助金额:$14.53万
-
财政年份:1978
-
负责人:RONALD S HARWERTH
-
依托单位:
Behavioral Measures of Vision
-
批准号:7925275
-
项目类别:
-
资助金额:$16.85万
-
财政年份:1978
-
负责人:RONALD S HARWERTH
-
依托单位:
BEHAVIORAL MEASURES OF BINOCULAR VISION
-
批准号:2158054
-
项目类别:
-
资助金额:$19.23万
-
财政年份:1978
-
负责人:RONALD S HARWERTH
-
依托单位:
BEHAVIORAL MEASURES OF BINOCULAR VISION
-
批准号:3255706
-
项目类别:
-
资助金额:$13.6万
-
财政年份:1978
-
负责人:RONALD S HARWERTH
-
依托单位:
Behavioral Measures of Binocular Vision
-
批准号:6621346
-
项目类别:
-
资助金额:$29.7万
-
财政年份:1978
-
负责人:RONALD S HARWERTH
-
依托单位:
BEHAVIORAL MEASURES OF BINOCULAR VISION
-
批准号:2019387
-
项目类别:
-
资助金额:$24.47万
-
财政年份:1978
-
负责人:RONALD S HARWERTH
-
依托单位:
BEHAVIORAL MEASURES OF BINOCULAR VISION
-
批准号:3255708
-
项目类别:
-
资助金额:$22.11万
-
财政年份:1978
-
负责人:RONALD S HARWERTH
-
依托单位:
BEHAVIORAL MEASURES OF BINOCULAR VISION
-
批准号:3255705
-
项目类别:
-
资助金额:$14.04万
-
财政年份:1978
-
负责人:RONALD S HARWERTH
-
依托单位:
BEHAVIORAL MEASURES OF BINOCULAR VISION
-
批准号:2856880
-
项目类别:
-
资助金额:$19.58万
-
财政年份:1978
-
负责人:RONALD S HARWERTH
-
依托单位:
Behavioral Measures of Binocular Vision
-
批准号:6836517
-
项目类别:
-
资助金额:$29.7万
-
财政年份:1978
-
负责人:RONALD S HARWERTH
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: